1962
DOI: 10.1007/978-3-662-28643-2_4
|View full text |Cite
|
Sign up to set email alerts
|

Die Pathologie der Avitaminosen und Hypervitaminosen

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0
1

Year Published

1965
1965
2011
2011

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 1,158 publications
0
2
0
1
Order By: Relevance
“…It is classified by the Food and Drug Administration as a Generally Recognized as Safe (GRAS) product (21 CFR 184, 1695(21 CFR 184, , 2001). The safety of RB has been demonstrated for oral, subcutaneous, intraperitoneal and intravenous routes of administration [13][14][15][16]. Neonates undergoing phototherapy for neonatal jaundice are often temporarily RB-deficient due to the overlapping light absorption spectra of RB and bilirubin [17][18][19][20].…”
Section: Toxicology and Safetymentioning
confidence: 99%
See 1 more Smart Citation
“…It is classified by the Food and Drug Administration as a Generally Recognized as Safe (GRAS) product (21 CFR 184, 1695(21 CFR 184, , 2001). The safety of RB has been demonstrated for oral, subcutaneous, intraperitoneal and intravenous routes of administration [13][14][15][16]. Neonates undergoing phototherapy for neonatal jaundice are often temporarily RB-deficient due to the overlapping light absorption spectra of RB and bilirubin [17][18][19][20].…”
Section: Toxicology and Safetymentioning
confidence: 99%
“…In patient samples from the MIRACLE clinical trial no RB was detected in any patient sample, and only traces of LC (0.06-0.07 μmol/l) were detected 24 h after transfusion in two patient samples analyzed (4%). Comparison of a RB exposure level of 0.077 mg/kg to the reported LD 50 for intravenous RB infusion in mice of 50-100 mg/kg [15] yields a large safety factor (649-1,299). The exposure level can also be compared to the levels of RB provided in parenteral nutrition.…”
Section: Introductionmentioning
confidence: 99%
“…Nach KUNZ, KRANZ und KEIM (1967) sowie JUNGE-HULSING, RAVE, WAGNER et al (1969) kommt es bei Ratten zunachst zu ,,erheblicher Akzeleration des Bindegewebsstoffwechsels" mit stark gesteigertem Sulfat-Einbau in die Mucopolysaccharide und nachfolgend zu Kalkablagerungen. Auch in ,,normal" alternden Aorten wurde bei Mensch, Ratte, Rind, Schwein und Hund eine Anhaufung von sauren Mucopolysacchariden beobachtet (SCHALLOCK, 1958;BUDDECKE, 1960), auf die besondere Bedeutung dieser sauren Bindegewebsbestandteile fur die Gewebsverkalkung wurde immer wieder hingewiesen (HOLMAN und MCCANE, 1956;SCHALLOCK, 1958;BUDDECKE, 1960;STUDER, ZBINDEN und UEHLINGER, 1962;STUDER und REBER, 1963;KOHLER, 1964;STUNZI, 1967;KOPPEL, SCHUTZLER und HORN, 1971;KOBAYASHI, 1971;u.a.). Analog dazu fanden GERLACH und THEMAN (1965 a, b)…”
Section: Der Genaue Ablauf Der Weichgewebeverkalkungen Unter Einff Uiunclassified